Authors: Vierboom, MPM Bos, GMJ Ooms, M Offringa, R Melief, CJM

Citation: Mpm. Vierboom et al., Cyclophosphamide enhances anti-tubor effect of wild-type p53-specific CTL, INT J CANC, 87(2), 2000, pp. 253-260

Authors: Vierboom, MPM Zwaveling, S Bos, GMJ Ooms, M Krietemeijer, GM Melief, CJM Offringa, R

Citation: Mpm. Vierboom et al., High steady-state levels of p53 are not a prerequisite for tumor eradication by wild-type p53-specific cytotoxic T lymphocytes, CANCER RES, 60(19), 2000, pp. 5508-5513

Authors: Vierboom, MPM Gabrilovich, DI Offringa, R Kast, WM Melief, CJM

Citation: Mpm. Vierboom et al., p53: A target for T-cell mediated immunotherapy, MED INTEL U, 24, 2000, pp. 40-55

Authors: Offringa, R Toes, REM Ressing, ME Vierboom, MPM Ossendorp, F Van der Burg, SH Nijman, HW Kast, WM Melief, CJM

Citation: R. Offringa et al., Antitumor vaccination using peptide-based vaccines, RESEARCH IN, 1998, pp. 205-215